From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix.
about
Recent Advances in Subunit Vaccine CarriersCrystallographic and mutational analyses of substrate recognition of endo-alpha-N-acetylgalactosaminidase from Bifidobacterium longumDeciphering Structural Elements of Mucin Glycoprotein RecognitionChemical O-Glycosylations: An OverviewHemocyanin from the keyhole limpet Megathura crenulata (KLH) carries a novel type of N-glycans with Gal(beta1-6)Man-motifs.A novel Gal(beta1-4)Gal(beta1-4)Fuc(alpha1-6)-core modification attached to the proximal N-acetylglucosamine of keyhole limpet haemocyanin (KLH) N-glycans.Identification and characterization of keyhole limpet hemocyanin N-glycans mediating cross-reactivity with Schistosoma mansoni.From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccineThe lectin concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKgamma/NF-kappaB-dependent pathway.Chemoenzymatic Syntheses of Tumor-Associated Carbohydrate Antigen Globo-H and Stage-Specific Embryonic Antigen 4.Erythropoietin derived by chemical synthesis.Alterations in glycopeptides associated with herceptin treatment of human breast carcinoma mcf-7 and T-lymphoblastoid cellsEmerging themes in medicinal glycoscience.ABH and Lewis histo-blood group antigens in cancer.Carbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen.The Amazing Transglycosylation Activity of Endo-β-N-acetylglucosaminidasesCarbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.Encouraging progress in the ω-aspartylation of complex oligosaccharides as a general route to β-N-linked glycopolypeptides.Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens.Synthesis and Evaluation of Protein Conjugates of GM3 Derivatives Carrying Modified Sialic Acids as Highly Immunogenic Cancer Vaccine CandidatesPreparation and immunological studies of protein conjugates of N -acylneuraminic acids.Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines.Synthesis of Carbohydrate Capped Silicon Nanoparticles and their Reduced Cytotoxicity, In Vivo Toxicity, and Cellular Uptake.Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouseLipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.Recent Development in Carbohydrate Based Anti-cancer Vaccines.Recent Advances in Transition Metal-Catalyzed GlycosylationTobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens.Automated synthesis of oligosaccharides as a basis for drug discovery.Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities.Solving the convergence problem in the synthesis of triantennary N-glycan relevant to prostate-specific membrane antigen (PSMA).Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies.Scalable synthesis of Fmoc-protected GalNAc-threonine amino acid and T(N) antigen via nickel catalysis.Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines.Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccinesMulti-component one-pot synthesis of the tumor-associated carbohydrate antigen Globo-H based on preactivation of thioglycosyl donors.Syntheses of Lewis(x) and dimeric Lewis(x): construction of branched oligosaccharides by a combination of preactivation and reactivity based chemoselective one-pot glycosylationsSynthetic and immunological studies of 5'-N-phenylacetyl sTn to develop carbohydrate-based cancer vaccines and to explore the impacts of linkage between carbohydrate antigens and carrier proteinsBiologics through chemistry: total synthesis of a proposed dual-acting vaccine targeting ovarian cancer by orchestration of oligosaccharide and polypeptide domains.Efficient and Regioselective Synthesis of β-GalNAc/GlcNAc-Lactose by a Bifunctional Transglycosylating β-N-Acetylhexosaminidase from Bifidobacterium bifidum.
P2860
Q26750929-998CDC64-2A32-4651-9BBE-A2016CF360B6Q27655782-CCF184CF-310C-410A-AAA3-076569E2FFEBQ27678183-BE7DEB2C-81D4-4729-8AAE-37A3230D3C2AQ28078454-9F34CA95-606D-404C-B3A0-23159FFCCC94Q30754857-90ECA9F8-FF63-4657-884D-C02815B24C73Q31024258-912FD145-365A-4EB6-BB02-BE1BF0042A1EQ33222662-D911C30F-A689-495C-9A5E-1071079F580DQ33466255-851AF136-4DAC-4582-820F-FD4B2AE51595Q33651146-6221B525-F716-49BB-9D02-98B2CFA4C49CQ33740597-92CBE788-6A57-41EB-89F6-3E5F9F283FC5Q33840717-458327BE-A335-4957-B407-C18A4D407E65Q33910762-3421BDB4-0577-4D4E-BFA8-E20128B88678Q33995031-A132E3A4-A013-4C5F-BADF-B3B5B48955C9Q34215529-89079D2A-9696-4DC5-BD53-6AEDE77995A1Q34248323-B68AB04C-11E0-43F8-ABEB-68887A25113BQ34314203-D11A57D0-6D37-449F-87E5-3ACAC2723EFBQ34478719-D06EDA92-46B6-4CF3-BAAE-33FCBBA8854FQ34550860-6F4D566E-A9B8-49CA-99CD-781A2344FDCDQ35079733-A275EB57-0828-4CF5-B563-2269DB4FCA0FQ35212122-0F28C6A0-C577-4866-BC09-079FAE3F191BQ35228550-BAFF38A2-DBB4-4B10-BFB3-7421D307376FQ35234194-3631C219-54E5-4BC0-97C3-F4F2BF5DE4FEQ35677032-2DFC6155-FB12-4BD2-9B70-43F1306D94A9Q35685656-CD042AB7-0801-48C5-93C3-3D415DBAEF87Q35705462-63A8F03D-83C6-431E-94E8-AFA55D95C83AQ35854131-8BBD8D24-9280-42A6-A273-2C8D2F364856Q36178568-19C2DF2E-8971-4567-A084-82AB1D9536F0Q36186712-612FFCBC-971E-4601-96E0-793F4370ACD9Q36247089-01FC5A2F-C352-4E78-B634-4D1E4A155F9CQ36284550-88B037CF-B6BE-44AB-9C7F-027BCA95155EQ36313627-09EE3E53-03AA-4EE2-B441-DED0038627C4Q36501284-F2501B2F-C87B-420F-AC84-5BC0674B6A9CQ36576120-51738BBD-0B7E-4288-AC1F-E9D26297038DQ36802325-697B16C3-83A0-4437-ACF2-8B09E3F17BC3Q36868822-52B392B0-0B6C-4305-AABA-2D2188B19DDCQ36871187-0DB07783-EFA4-4BC4-A388-5A7BEA85D5FEQ36995942-6BBF2BBB-5814-4975-8813-6BC9D3573FBFQ37120643-0300B5E4-AB3C-470B-B3C3-69B01DDF83E0Q37186518-3000E339-6177-4C74-AC67-1C19C2E65748Q37224134-7485EB6A-EC19-4EDC-A8AE-68D70F5E1BA4
P2860
From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
From the Laboratory to the Cli ...... ns are listed in the appendix.
@ast
From the Laboratory to the Cli ...... ns are listed in the appendix.
@en
type
label
From the Laboratory to the Cli ...... ns are listed in the appendix.
@ast
From the Laboratory to the Cli ...... ns are listed in the appendix.
@en
prefLabel
From the Laboratory to the Cli ...... ns are listed in the appendix.
@ast
From the Laboratory to the Cli ...... ns are listed in the appendix.
@en
P1433
P1476
From the Laboratory to the Cli ...... ns are listed in the appendix.
@en
P2093
Danishefsky SJ
P304
P356
10.1002/(SICI)1521-3773(20000303)39:5<836::AID-ANIE836>3.0.CO;2-I
P577
2000-03-01T00:00:00Z